The Cardiovascular Risk of Proton Pump Inhibitors and the Dangers of Polypharmacy.

Mayo Clin Proc

MedStar Health Research Institute, Washington, DC; Georgetown University, Washington, DC. Electronic address:

Published: October 2021

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mayocp.2021.08.017DOI Listing

Publication Analysis

Top Keywords

cardiovascular risk
4
risk proton
4
proton pump
4
pump inhibitors
4
inhibitors dangers
4
dangers polypharmacy
4
cardiovascular
1
proton
1
pump
1
inhibitors
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!